Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Saitta

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
British Journal of Pharmacology|December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.
Pharmacological Research|July 1, 1995
Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor testA Saitta, M Bonaiuto, A Mileto, et al.
Angiology|November 20, 1998
Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery diseaseA Saitta, A Sardo, M Bonaiuto, et al.
Minerva Medica|July 1, 1997
[Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension]A Saitta, M N Saitta, A Messina, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 1, 1996
Acute cardiovascular effects of salmeterol in subjects with stable bronchial asthmaG F Bagnato, A Mileto, S Gulli, et al.
International Journal of Obesity (2005)|October 19, 2006
Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patientsF Corica, A Corsonello, M Lucchetti, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockF Squadrito, D Altavilla, B Zingarelli, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
British Journal of Pharmacology|June 29, 1999
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shockF Squadrito, D Altavilla, G Squadrito, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
British Journal of Pharmacology|December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.
Pharmacological Research|July 1, 1995
Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor testA Saitta, M Bonaiuto, A Mileto, et al.
Angiology|November 20, 1998
Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery diseaseA Saitta, A Sardo, M Bonaiuto, et al.
Minerva Medica|July 1, 1997
[Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension]A Saitta, M N Saitta, A Messina, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 1, 1996
Acute cardiovascular effects of salmeterol in subjects with stable bronchial asthmaG F Bagnato, A Mileto, S Gulli, et al.
International Journal of Obesity (2005)|October 19, 2006
Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patientsF Corica, A Corsonello, M Lucchetti, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockF Squadrito, D Altavilla, B Zingarelli, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
British Journal of Pharmacology|June 29, 1999
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shockF Squadrito, D Altavilla, G Squadrito, et al.
Pageof 12